Gene Engineered Subunit Vaccine Market, Global Outlook and Forecast 2022-2028

January 2022 | 61 pages | ID: GC03365D2B33EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
A gene engineered subunit vaccine or a bio-recombinant subunit vaccine refers to the expression of a protective antigen gene in a prokaryotic or eukaryotic cell, and a vaccine made from a gene product—protein or polypeptide.

This report contains market size and forecasts of Gene Engineered Subunit Vaccine in Global, including the following market information:

Global Gene Engineered Subunit Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Gene Engineered Subunit Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Therapeutic Gene Engineered Subunit Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gene Engineered Subunit Vaccine include Merck, GSK, Tiantan, Pulike, Greffex, CureVac, Yebio, Sanofi Pasteur SA and Virbac, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Engineered Subunit Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gene Engineered Subunit Vaccine Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Gene Engineered Subunit Vaccine Market Segment Percentages, by Type, 2021 (%)
  • Therapeutic Gene Engineered Subunit Vaccine
  • Preventative Gene Engineered Subunit Vaccine
Global Gene Engineered Subunit Vaccine Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Gene Engineered Subunit Vaccine Market Segment Percentages, by Application, 2021 (%)
  • Human Use
  • Veterinary Use
Global Gene Engineered Subunit Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Gene Engineered Subunit Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gene Engineered Subunit Vaccine revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Gene Engineered Subunit Vaccine revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Merck
  • GSK
  • Tiantan
  • Pulike
  • Greffex
  • CureVac
  • Yebio
  • Sanofi Pasteur SA
  • Virbac
  • Pfizer Inc.
  • Walvax Biotechnology
  • Kontec
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gene Engineered Subunit Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gene Engineered Subunit Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENE ENGINEERED SUBUNIT VACCINE OVERALL MARKET SIZE

2.1 Global Gene Engineered Subunit Vaccine Market Size: 2021 VS 2028
2.2 Global Gene Engineered Subunit Vaccine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gene Engineered Subunit Vaccine Players in Global Market
3.2 Top Global Gene Engineered Subunit Vaccine Companies Ranked by Revenue
3.3 Global Gene Engineered Subunit Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Gene Engineered Subunit Vaccine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gene Engineered Subunit Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Engineered Subunit Vaccine Players in Global Market
  3.6.1 List of Global Tier 1 Gene Engineered Subunit Vaccine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gene Engineered Subunit Vaccine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gene Engineered Subunit Vaccine Market Size Markets, 2021 & 2028
  4.1.2 Therapeutic Gene Engineered Subunit Vaccine
  4.1.3 Preventative Gene Engineered Subunit Vaccine
4.2 By Type - Global Gene Engineered Subunit Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Gene Engineered Subunit Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Gene Engineered Subunit Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gene Engineered Subunit Vaccine Market Size, 2021 & 2028
  5.1.2 Human Use
  5.1.3 Veterinary Use
5.2 By Application - Global Gene Engineered Subunit Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Gene Engineered Subunit Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Gene Engineered Subunit Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gene Engineered Subunit Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Gene Engineered Subunit Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Gene Engineered Subunit Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Gene Engineered Subunit Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gene Engineered Subunit Vaccine Revenue, 2017-2028
  6.3.2 US Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.3.3 Canada Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.3.4 Mexico Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gene Engineered Subunit Vaccine Revenue, 2017-2028
  6.4.2 Germany Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.4.3 France Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.4.4 U.K. Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.4.5 Italy Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.4.6 Russia Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.4.7 Nordic Countries Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.4.8 Benelux Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gene Engineered Subunit Vaccine Revenue, 2017-2028
  6.5.2 China Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.5.3 Japan Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.5.4 South Korea Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.5.5 Southeast Asia Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.5.6 India Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gene Engineered Subunit Vaccine Revenue, 2017-2028
  6.6.2 Brazil Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.6.3 Argentina Gene Engineered Subunit Vaccine Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gene Engineered Subunit Vaccine Revenue, 2017-2028
  6.7.2 Turkey Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.7.3 Israel Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.7.4 Saudi Arabia Gene Engineered Subunit Vaccine Market Size, 2017-2028
  6.7.5 UAE Gene Engineered Subunit Vaccine Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Gene Engineered Subunit Vaccine Major Product Offerings
  7.1.4 Merck Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 GSK
  7.2.1 GSK Corporate Summary
  7.2.2 GSK Business Overview
  7.2.3 GSK Gene Engineered Subunit Vaccine Major Product Offerings
  7.2.4 GSK Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
  7.2.5 GSK Key News
7.3 Tiantan
  7.3.1 Tiantan Corporate Summary
  7.3.2 Tiantan Business Overview
  7.3.3 Tiantan Gene Engineered Subunit Vaccine Major Product Offerings
  7.3.4 Tiantan Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
  7.3.5 Tiantan Key News
7.4 Pulike
  7.4.1 Pulike Corporate Summary
  7.4.2 Pulike Business Overview
  7.4.3 Pulike Gene Engineered Subunit Vaccine Major Product Offerings
  7.4.4 Pulike Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
  7.4.5 Pulike Key News
7.5 Greffex
  7.5.1 Greffex Corporate Summary
  7.5.2 Greffex Business Overview
  7.5.3 Greffex Gene Engineered Subunit Vaccine Major Product Offerings
  7.5.4 Greffex Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
  7.5.5 Greffex Key News
7.6 CureVac
  7.6.1 CureVac Corporate Summary
  7.6.2 CureVac Business Overview
  7.6.3 CureVac Gene Engineered Subunit Vaccine Major Product Offerings
  7.6.4 CureVac Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
  7.6.5 CureVac Key News
7.7 Yebio
  7.7.1 Yebio Corporate Summary
  7.7.2 Yebio Business Overview
  7.7.3 Yebio Gene Engineered Subunit Vaccine Major Product Offerings
  7.7.4 Yebio Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
  7.7.5 Yebio Key News
7.8 Sanofi Pasteur SA
  7.8.1 Sanofi Pasteur SA Corporate Summary
  7.8.2 Sanofi Pasteur SA Business Overview
  7.8.3 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Major Product Offerings
  7.8.4 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
  7.8.5 Sanofi Pasteur SA Key News
7.9 Virbac
  7.9.1 Virbac Corporate Summary
  7.9.2 Virbac Business Overview
  7.9.3 Virbac Gene Engineered Subunit Vaccine Major Product Offerings
  7.9.4 Virbac Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
  7.9.5 Virbac Key News
7.10 Pfizer Inc.
  7.10.1 Pfizer Inc. Corporate Summary
  7.10.2 Pfizer Inc. Business Overview
  7.10.3 Pfizer Inc. Gene Engineered Subunit Vaccine Major Product Offerings
  7.10.4 Pfizer Inc. Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
  7.10.5 Pfizer Inc. Key News
7.11 Walvax Biotechnology
  7.11.1 Walvax Biotechnology Corporate Summary
  7.11.2 Walvax Biotechnology Business Overview
  7.11.3 Walvax Biotechnology Gene Engineered Subunit Vaccine Major Product Offerings
  7.11.4 Walvax Biotechnology Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
  7.11.5 Walvax Biotechnology Key News
7.12 Kontec
  7.12.1 Kontec Corporate Summary
  7.12.2 Kontec Business Overview
  7.12.3 Kontec Gene Engineered Subunit Vaccine Major Product Offerings
  7.12.4 Kontec Gene Engineered Subunit Vaccine Revenue in Global Market (2017-2022)
  7.12.5 Kontec Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Gene Engineered Subunit Vaccine Market Opportunities & Trends in Global Market
Table 2. Gene Engineered Subunit Vaccine Market Drivers in Global Market
Table 3. Gene Engineered Subunit Vaccine Market Restraints in Global Market
Table 4. Key Players of Gene Engineered Subunit Vaccine in Global Market
Table 5. Top Gene Engineered Subunit Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gene Engineered Subunit Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gene Engineered Subunit Vaccine Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gene Engineered Subunit Vaccine Product Type
Table 9. List of Global Tier 1 Gene Engineered Subunit Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Engineered Subunit Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gene Engineered Subunit Vaccine Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gene Engineered Subunit Vaccine Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gene Engineered Subunit Vaccine Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gene Engineered Subunit Vaccine Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gene Engineered Subunit Vaccine Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gene Engineered Subunit Vaccine Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Gene Engineered Subunit Vaccine Product Offerings
Table 32. Merck Gene Engineered Subunit Vaccine Revenue (US$, Mn), (2017-2022)
Table 33. GSK Corporate Summary
Table 34. GSK Gene Engineered Subunit Vaccine Product Offerings
Table 35. GSK Gene Engineered Subunit Vaccine Revenue (US$, Mn), (2017-2022)
Table 36. Tiantan Corporate Summary
Table 37. Tiantan Gene Engineered Subunit Vaccine Product Offerings
Table 38. Tiantan Gene Engineered Subunit Vaccine Revenue (US$, Mn), (2017-2022)
Table 39. Pulike Corporate Summary
Table 40. Pulike Gene Engineered Subunit Vaccine Product Offerings
Table 41. Pulike Gene Engineered Subunit Vaccine Revenue (US$, Mn), (2017-2022)
Table 42. Greffex Corporate Summary
Table 43. Greffex Gene Engineered Subunit Vaccine Product Offerings
Table 44. Greffex Gene Engineered Subunit Vaccine Revenue (US$, Mn), (2017-2022)
Table 45. CureVac Corporate Summary
Table 46. CureVac Gene Engineered Subunit Vaccine Product Offerings
Table 47. CureVac Gene Engineered Subunit Vaccine Revenue (US$, Mn), (2017-2022)
Table 48. Yebio Corporate Summary
Table 49. Yebio Gene Engineered Subunit Vaccine Product Offerings
Table 50. Yebio Gene Engineered Subunit Vaccine Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Pasteur SA Corporate Summary
Table 52. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product Offerings
Table 53. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Revenue (US$, Mn), (2017-2022)
Table 54. Virbac Corporate Summary
Table 55. Virbac Gene Engineered Subunit Vaccine Product Offerings
Table 56. Virbac Gene Engineered Subunit Vaccine Revenue (US$, Mn), (2017-2022)
Table 57. Pfizer Inc. Corporate Summary
Table 58. Pfizer Inc. Gene Engineered Subunit Vaccine Product Offerings
Table 59. Pfizer Inc. Gene Engineered Subunit Vaccine Revenue (US$, Mn), (2017-2022)
Table 60. Walvax Biotechnology Corporate Summary
Table 61. Walvax Biotechnology Gene Engineered Subunit Vaccine Product Offerings
Table 62. Walvax Biotechnology Gene Engineered Subunit Vaccine Revenue (US$, Mn), (2017-2022)
Table 63. Kontec Corporate Summary
Table 64. Kontec Gene Engineered Subunit Vaccine Product Offerings
Table 65. Kontec Gene Engineered Subunit Vaccine Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Gene Engineered Subunit Vaccine Segment by Type in 2021
Figure 2. Gene Engineered Subunit Vaccine Segment by Application in 2021
Figure 3. Global Gene Engineered Subunit Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gene Engineered Subunit Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gene Engineered Subunit Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Engineered Subunit Vaccine Revenue in 2021
Figure 8. By Type - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028
Figure 12. US Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028
Figure 16. Germany Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 17. France Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028
Figure 24. China Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. India Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028
Figure 30. Brazil Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gene Engineered Subunit Vaccine Revenue Market Share, 2017-2028
Figure 33. Turkey Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GSK Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Tiantan Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pulike Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Greffex Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. CureVac Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Yebio Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Virbac Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pfizer Inc. Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Walvax Biotechnology Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Kontec Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications